Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care.
Saved in:
| Title: | Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care. |
|---|---|
| Authors: | Frol S; Department of Vascular Neurology, University Medical Centre Ljubljana, Zaloška 2, 1000, Ljubljana, Slovenia. senta.frol@kclj.si.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. senta.frol@kclj.si., Zupan M; Department of Vascular Neurology, University Medical Centre Ljubljana, Zaloška 2, 1000, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Šabovič M; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Department of Vascular Disorders, University Medical Center Ljubljana, Ljubljana, Slovenia., Kermer P; Department of Neurology, University Medical Center, Göttingen, Germany.; Department of Neurology, Friesland Kliniken GmbH, Sande, Germany., Siddiqui AH; Jacobs Institute, SUNY University at Buffalo and Kaleida Health, Buffalo, NY, USA., Levy EI; Jacobs Institute, SUNY University at Buffalo and Kaleida Health, Buffalo, NY, USA. |
| Source: | CNS drugs [CNS Drugs] 2026 Jun; Vol. 40 (6), pp. 733-736. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
